se of Ayurvedic Medicines in skin disease
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: B354- Tinea corporis
- Registration Number
- CTRI/2022/02/040587
- Lead Sponsor
- Dr Suryakiran Parashuram Wagh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having the clinical features of dadru.
Patients ready to abide trial procedure to give
informed consent.
Exclusion Criteria
1. Patients aged below 14 & above 60 years.
2. Pregnant women & lactating mothers.
3. Patient of other skin disease like psoriasis, seborrhic
dermatitis, lichen simplex, chronicus, pityriasis
versicolor, eczema, candidiasis.
4. Patients having any known severe systemic diseases of renal,
hepatic cardiac disorders, diabeties mellitus,
tuberculosis, immuno deficiency syndrome, leprosy,
malignant disease.
5.Patients having known drug allergy of sulphur, mercury.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure of Dadru kushta signs and symptoms Kandu (Pruritus) <br/ ><br>Raga (Erythema) <br/ ><br>Number of Mandala <br/ ><br>Size of MandalaTimepoint: 2 months
- Secondary Outcome Measures
Name Time Method no recurrence of DadruTimepoint: 4 weeks